Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion.

Eli Lilly (LLY) is a leading pharmaceutical company that discovers, develops, manufactures, and markets healthcare products.

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

The pharmaceutical industry's patience is wearing thin with the Trump administration's pressure. But the administration doesn ...

The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from a patient.

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

With threats of additional tariffs targeting prescription drugs, pharmacists worry that costs will soar for medications.